Neuphoria Therapeutics Inc.
NEUP
$4.14
-$0.23-5.26%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/1/2025
-
GuruFocus
12/1/2025
-
The Fly
12/1/2025
-
Globe Newswire
11/24/2025
-
GuruFocus
11/24/2025
-
The Fly
11/24/2025
-
GuruFocus
11/24/2025
-
Globe Newswire
11/11/2025
-
Globe Newswire
11/11/2025
-
FierceBiotech.com - Biotech
11/5/2025
-
Simply Wall St
10/27/2025
-
GuruFocus
10/27/2025
-
Globe Newswire
10/27/2025
-
MarketBeat
10/26/2025
-
MarketBeat
10/25/2025
-
24/7 Wall St.
10/24/2025
-
Stocktwits News Feed
10/24/2025
-
MarketBeat
10/21/2025
-
FierceBiotech.com - Biotech
10/21/2025
-
The Fly
10/20/2025
-
GuruFocus
10/20/2025
-
GuruFocus
10/20/2025
-
TipRanks Financial Blog
10/20/2025
-
The Fly
10/20/2025
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 9 and 13 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 439 5551
Address
100 Summit Drive
Burlington, MA 01803
Burlington, MA 01803
Country
Year Founded
Business Description
Sector
Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, discovers and develops novel allosteric ion channel modulators for the treatment of central nervous system disorders in...
more